Queensland artificial intelligence technology has joined forces with the state's world-leading medical research institute to tailor cancer patients' treatment and improve its effectiveness. The collaboration is an Australian first, according to the researchers involved, and will span at least two years after receiving $2.6 million in funding from the federal government last week. The project will bring together medical institutes and specialised Brisbane research companies. Brisbane AI company Max Kelsen has partnered with the internationally renowned QIMR Berghofer Medical Research Institute, precision-analytics start-up genomiQa, genomics researcher BGI Australia and the Royal Brisbane and Women's Hospital. Cancer patients' genetics will be analysed by AI in the hope of finding more complex patterns and therefore helping doctors to decide which treatment would be most effective for the individuals.